スポンサーリンク
Division Of Oncology/hematology National Cancer Center Hospital East | 論文
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
- Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
- Treatment strategy for HER2-positive breast cancer
- Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
- Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
- Simultaneous determination of a new anticancer agent (NB-506) and its active metabolite in human plasma and urine by high-performance liquid chromatography with ultraviolet detection